CA Intermediate · Advanced Accounting · AS 4 Contingencies and Events occurring after the Balance Sheet Date
Nanda Pharma Ltd. closed its books on 31 March 2026, and the accounts were approved on 25 June 2026. On 12 May 2026 the company discovered that a fraud by its accountant during 2025-26 had resulted in misappropriation of Rs 9,00,000, which was not reflected in the books at year end. How should this be treated?
The loss of Rs 9,00,000 must be recognised in the 2025-26 accounts. The fraud took place during that year, and its discovery before approval shows the statements were incorrect at the balance sheet date, so it is an adjusting event rather than a mere disclosure item.
- ADisclose only as a non-adjusting event
- BAdjust the 2025-26 accounts by recognising the loss of Rs 9,00,000Correct
- CRecognise the loss in 2026-27 as a prior period item
- DNo action, as discovery was after the year end
Explanation
The fraud occurred during 2025-26, so the loss relates to a condition existing at the balance sheet date. Discovery of fraud or errors showing the financial statements were incorrect is an adjusting event. Hence the Rs 9,00,000 loss is recorded in 2025-26, not deferred.
Did you get it right without looking?
One question tells you little. A timed set on AS 4 Contingencies and Events occurring after the Balance Sheet Date shows your real accuracy, how long you take and where you lose marks.
More AS 4 Contingencies and Events occurring after the Balance Sheet Date questions
- Narmada Chemicals Ltd approved its financial statements for the year ended 31 March 2026 on 30 June 2026. The following events happened: (i)…
- Anand Engineering Ltd. closes its books on 31 March 2026. The financial statements were approved by the board on 10 June 2026. Which one of …
- Himalaya Foods Ltd prepares accounts for the year ended 31 March 2026, approved on 28 July 2026. Facts: (a) Closing stock of Rs 20,00,000 at…
- Zenith Textiles Ltd closes its books on 31 March 2026, and the financial statements were approved by the board on 20 May 2026. On 5 May 2026…
- Gupta Pharma Ltd. approved its financial statements for 2024-25 on 30 July 2025. On 15 April 2025 the Board proposed a dividend of Rs 12 lak…
- Mehta Engineering Ltd. has a year ending 31 March 2025 and its accounts were approved on 25 June 2025. A customer, Sharma Traders, owed Rs 6…